|
Up a level |
Distler, J H W; Jordan, S; Airo, P; Alegre-Sancho, J J; Allanore, Y; Balbir Gurman, A; Caporali, R; Caramaschi, P; Carreira, P E; Chizzolini, C; Cutolo, M; Tuncay Duruöz, M; Farge-Bancel, D; Hesselstrand, R; Iannone, F; De Keyser, F; Kucharz, E J; Launay, D; García de la Peña Lefebvre, P; Lukacova, O; Marasini, B; Martinovic, D; Marques Neto, J F; Radic, M; Rednic, S; Riemekasten, G; Rovensky, J; Seidel, M F; Senel, S; Smith, V; Sunderkötter, C; Ton, E; van Laar, J M; Matucci-Cerinic, M; Müller Ladner, U; Distler, O (2011). Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique. Clinical and Experimental Rheumatology, 29(2 Suppl 65):S40-S45.
Daikeler, T; Labopin, M; Di Gioia, M; Abinun, M; Alexander, T; Miniati, I; Gualandi, F; Fassas, A; Martin, T; Schwarze, C P; Wulffraat, N; Buch, M; Sampol, A; Carreras, E; Dubois, B; Gruhn, B; Güngör, T; Pohlreich, D; Schuerwegh, A; Snarski, E; Snowden, J; Veys, P; Fasth, A; Lenhoff, S; Messina, C; Voswinkel, J; Badoglio, M; Henes, J; Launay, D; Tyndall, A; Gluckman, E; Farge, D (2011). Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party. Blood, 118(6):1693-1698.